Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Central 5-HT2C receptor agonist exerts proerectile activity in two animal species

Oct. 9, 2000

Vardenafil's preclinical profile supports potential in ED; other PDE5 inhibitors in the pipeline

Oct. 9, 2000

IC-351 effective and safe as once-daily or on-demand therapy for ED

Oct. 6, 2000

Selective V2 receptor agonists from AHP and their use described in patents

Sep. 25, 2000

Recordati identifies potent and selective alpha1D-adrenoceptor antagonists based on BMY-7378

Sep. 21, 2000

Enrollment completed in pivotal phase III trial of Chondrogel

Sep. 21, 2000

Sanofi-Synthelabo discloses synthesis and use of new alpha-azacyclomethylquinolines

Sep. 19, 2000

Preclinical results in guinea pigs suggest novel mechanism of action for TAK-637

Sep. 18, 2000

Update on U.S. status of Zonagen's sexual dysfunction products

Sep. 15, 2000

Cystistat approved for expanded indications in Europe

Sep. 14, 2000

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...